05:02 PM EDT, 06/04/2026 (MT Newswires) -- Ensysce Biosciences ( ENSC ) filed a registration statement with the US Securities and Exchange Commission late Thursday for the resale of up to 1.3 million shares.
The company said the selling securityholders will receive all proceeds from the offering.